1: Haemostasis Flashcards

1
Q

2 factors necessary for maintaining circulation of blood in fluid state to blood vessels

A

Fibrinolytic anticoagulant proteins
Coagulation factors, platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Structure of platelets (3)

A

Discoid
Non-nucleated
Granule-containing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where and how are platelets formed

A

Bone marrow
Fragmentation of megakaryocytic cytoplasm from myeloid stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Haemostasis is

A

Halting of blood following trauma to blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 functions of haemostasis

A

Prevention of blood loss from intact vessels
Arrest of bleeding from injured vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Balance in haemostasis is important for (3)

A

Coagulation
Prevents thrombosis
Fibrinolysis - break down of clot as part of healing process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanism of haemostasis

A

1) Response to injury ( vessel constriction)
2) [1°] unstable platelet plug formation (platelet adhesion and aggregation)
3) [2°]stabilisation of platelet plug with fibrin (blood coagulation)
4) [fibrinolysis] dissolution of clot and vessel repair (cell proliferation + fibrinolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary haemostasis is

A

Formation of unstable platelet plug
- platelet adhesion
-platelet activation
-platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Platelets are

A

Granule cont. cells
Made from myeloid stem cells
Plasma membrane contains glycoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lifespan of platelets

A

10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Formation of unstable platelet plug

A
  1. Platelet adhesion
  2. Platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Process of Platelet adhesion

A

Collagen exposed on endothelium of damaged vessel wall
Platelets stick to collagen directly via GP1a
Stick to VWF (Von willebrand factor) which binds to GP1b on collagen
Adhesion activates platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Process of platelet activation

A

platelets activated after adhesion

releases alpha granules and dense granules (storage)
stored granules also release ADP, VWF, fibrinogen
platelets produce thromboxane A2 from arachidonic acid (plasma membrane)
conformational change in GP2b/3a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

process of platelet aggregation

A

Thromboxane A2 and ADP have positive feedback on platelet recruitment, activation and aggregation
ADP binds to P2Y12 receptor and thromboxane A2 binds to thromboxane A2 receptor
GP2b/3a allows binding of fibrinogen and calcium
fibrinogen links platelets to form unstable platelet plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arachidonic acid produces ______ which inhibits platelet adhesion and aggregation, how?

A

Prostacyclin (PGI)
- released from endothelial cells
- vasodilator
- supresses platelet activation to avoid inappropriate aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is dosage of antiplatelet drugs important

A

platelets have a lifespan of 10 days
dose lasts around 7 days until all platelets are replaced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2 antiplatelet drugs

A

aspirin
clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does aspirin act as an antiplatelet drug

A

Irreversibly blocks COX (enzyme)
inhibits thromboxane A2 production
so platelet activation inhibited
[PGI production also inhibited by blocking COX, but endothelial cells can produce more COX, but platelets can’t)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does Clopidogrel act as an antiplatelet drug

A

Irreversibly blocks ADP receptor (P2Y12) on platelet cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Secondary haemostasis is

A

formation of stable fibrin clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Reason for stabilisation of primary platelet plug

A

sufficient for small vessel injury
in larger vessels it falls apart
fibrin formation stabilises it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Process of primary platelet plug stabilisation

A

Blood coagulation generates thrombin
cleaves fibrinogen to generate fibrin clot, stabilising platelet plug at site of injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Synthesis of clotting factors

A

most made in liver (12 total)
factor VIII and VWF made by endothelial cells
VWF also made in megakaryocytes and put into platelet granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do clotting factors produce fibrin

A

work in a cascade to produce fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is Vitamin K needed for in secondary haemostasis
carboxylation of factors II, VII, IX and X (2,7,9,10)
26
How do clotting factors work
bind to exposed phospholipid surfaces of platelets -helps localise and accelerate reaction Ca2+ important for binding of clotting factors to surfaces convert inactive zymogen (proenzyme) into active clotting factor factors V and VIII are co-factors
27
3 Phases of Coagulation (cellular based model)
initiation phase amplification phase propagation phase
28
In the initiation phase of coagulation
Tissue factor (TF) exposed on endothelial cell surface post injury TF binds to 7a --- activates 9--- 9a and 10--- 10a --- activation of prothrombin (factor2)--- small amount of thrombin (factor 2a)
29
In the amplification phase of coagulation
small amount of thrombin activates cofactors 5 and 8, zymogen factor 9 and platelets
30
In the propagation phase of coagulation
activated factor 9 (9 to 9a) with 8a form 10 to 10a - rapid burst in thrombin thrombin cleaves soluble fibrinogen to form insoluble fibrin clot
31
3 Natural anticoagulants
confine coagulation to site of injury only - protein C, protein S and antithrombin
32
How do protein C, S and antithrombin act as natural anticoagulants
-thrombin binds to thrombomodulin on endothelial cell surface leads to activation of protein C to activated protein C (APC) APC inactivates factors Va and VIIIa in presence of co-factor protein S -thrombin and factor Xa inactivated by circulating inhibitor antithrombin
33
3 Anticoagulant drugs
Heparin Warfarin DOACs (Direct oral anticoagulants)
34
How does Heparin work as an anticoagulant drug
Works indirectly by potentiating action of antithrombin leading to inactivation of factors Xa and IIa (thrombin) administered intravenously or by subcutaneous injection
35
How does Warfarin work as an anticoagulant drug
Vit K antagonist : interfere with protein carboxylation reduces synthesis of functional factors, 2,7,9,10 by liver Given as an oral tablet, effects monitored by regular blood testing several days to work
36
How do DOACs work as an anticoagulant drug
Orally available drugs that directly inhibit either thrombin or factor Xa Do not require monitoring
37
Fibrinolysis is
Vessel repair and dissolution of clot
38
Main fibrinolytic enzyme
plasmin
39
How does plasmin work
Plasminogen (inactive zymogen form) circulates in blood Tissue plasminogen activator (t-PA) and plasminogen bind to lysine residues on fibrin break down fibrin into fibrin degradation products (FDPs)
40
2 things inhibiting plasmin
Antiplasmin (circulating in blood) alpha 2 macroglobulin
41
Thrombolytic therapy is
artificial fibrinolysis
42
Example of thrombolytic therapy
Recombinant t-PA generate plasmin to lyse clots, break down fibrin to FDPs - administered intravenously to patients presenting with ischaemic stroke - needs to be given ASAP, preferably within 1h to onset of symptoms - can be administered to patients with pulmonary emboli
43
Function of antifibrinolytic drugs
- stops body breaking fibrin clot - keep clots = bleed less
44
Effects of Tranexamic acid as an antifibrinolytic drug
Antifibrinolytic drug derived from lysine binds to plasminogen and prevents it from binding to lysine on fibrin Competitive inhibitor - treats: bleeding in trauma, surgical patients, patients with bleeding disorders
45
Test of coagulation - common pathway
Factors V and X form factor II Which converts Fibrinogen to Fibrin
46
Test of coagulation - Extrinsic pathway
PT (prothrombin time) VII a converts TF into factor X then follows common pathway
47
Test of coagulation - Intrinsic pathway
APTT PK - XII converted into XI converted into VIII and IX both converted to factor X and follow common pathway
48
INR is
standardising method of Prothrombin time for comparison
49
Prothrombin time PT measures
integrity of extrinsic pathway
50
How to measure PT
- Blood collected in bottle containing sodium citrate - chelates calcium- preventing clotting in bottle - sample spun to produce platelet-poor plasma -source of TF, calcium and phospholipid added to start reaction - length of time taken for mixture to clot is recorded
51
Activated partial thromboplastin time (APTT) measures
integrity of intrinsic pathway
52
Prolonged APPT and normal Pt seen in what 4 conditions
Haemophilia A (FVIII deficiency) Haemophilia B (FIX deficiency) Factor XI deficiency Factor XII deficiency - no bleeding
53
How to measure APTT
Contact activation of factor XII by glass or using silica or kaolin contact activator, together with phospholipid, added to citrated plasma sample followed by calcium time taken for mixture to clot is measured
54
Prolonged PT signifies
reduction in FVII, X, V, prothrombin or fibrinogen activity
55
3 Things that increase bleeding
- Reduction in platelet number (thrombocytopenia) or function (primary haemostasis - platelet plug) - Reduction in coagulation factors (secondary haemostasis - fibrin clot) - Increased fibrinolysis
56
Virchows triad
3 most important factors in blood clot formation: Blood - dominant in venous thrombosis Vessel wall - dominant in arterial thrombosis Blood flow - complex and contributes to both
57
Venous thrombosis is
Blood clots forming in veins
58
2 main things that occur in venous thrombosis
Decrease in fibrinolytic factors and anticoagulant proteins Increase in coagulation factors and platelets
59
What factors cause a decrease in fibrinolysis and anticoagulant proteins in venous thrombosis
pregnancy - inhibition of plasminogen, activation through placental production of inhibitor PAI-2 genetics - inherited antithrombin deficiency
60
what factor increases coagulation factors and platelets leading to venous thrombosis
levels of FVIII increase in pregnancy FV leiden - mutation in FV gene makes it more resistant to inactivation by protein C Myeloproliferative disorders cause incr. in platelet output by bone marrow